Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jan 21, 2025 (2 years ago)

Irbesartan Tablets USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Out of Specification for Dissolution

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Affected NDC 50268-0442-15

Compare with the code on your package — it is the most precise check available.

Drug: Irbesartan Category: Blood Pressure Medication

Recalling firm
AvKARE
NDC code
50268-442-15
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0224-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Irbesartan recalls

See all
Class II · Moderate risk

Irbesartan Tablets

Failed Dissolution Specifications

Terminated Dissolution failure Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-447-90 D-1294-2022
Class II · Moderate risk

Irbesartan Tablets

Failed dissolution specifications.

Terminated Dissolution failure Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-448-90 D-1293-2022
Class II · Moderate risk

Irbesartan Tablets USP

CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Terminated Nitrosamine impurity Lupin Pharmaceuticals Inc. NDC 68180-412-06 D-0088-2022

Other recalls by AvKARE

All 2025 recalls
Class II · Moderate risk

Amantadine HCl

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Ongoing Dissolution failure AvKARE NDC 50268-069-15 D-0341-2026